Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Chelating Polymers for Hereditary Hemochromatosis Treatment

O. Groborz, L. Poláková, K. Kolouchová, P. Švec, L. Loukotová, VM. Miriyala, P. Francová, J. Kučka, J. Krijt, P. Páral, M. Báječný, T. Heizer, R. Pohl, D. Dunlop, J. Czernek, L. Šefc, J. Beneš, P. Štěpánek, P. Hobza, M. Hrubý

. 2020 ; 20 (12) : e2000254. [pub] 20200921

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004789

Hemochromatosis (iron overload) encompasses a group of diseases that are characterized by a toxic hyperaccumulation of iron in parenchymal organs. Currently, only few treatments for this disease have been approved; however, all these treatments possess severe side effects. In this study, a paradigm for hemochromatosis maintenance/preventive therapy is investigated: polymers with negligible systemic biological availability form stable complexes with iron ions in the gastrointestinal tract, which reduces the biological availability of iron. Macroporous polymer beads are synthesized with three different iron-chelating moieties (benzene-1,2-diol, benzene-1,2,3-triol, and 1,10-phenanthroline). The polymers rapidly chelate iron ions from aqueous solutions in vitro in the course of minutes, and are noncytotoxic and nonprooxidant. Moreover, the in vivo biodistribution and pharmacokinetics show a negligible uptake from the gastrointestinal tract (using 125 I-labeled polymer and single photon emission computed tomography/computed tomography), which generally prevents them from having systemic side effects. The therapeutic efficacy of the prepared polymers is successfully tested in vivo, and exhibits a significant inhibition of iron uptake from the gastrointestinal tract without any noticeable signs of toxicity. Furthermore, an in silico method is developed for the prediction of chelator selectivity. Therefore, this paradigm can be applied to the next-generation maintenance/preventive treatment for hemochromatosis and/or other diseases of similar pathophysiology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004789
003      
CZ-PrNML
005      
20220127144956.0
007      
ta
008      
220113s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/mabi.202000254 $2 doi
035    __
$a (PubMed)32954629
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Groborz, Ondřej $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic $u Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Salmovská 1, 120 00, Prague 2, Czech Republic
245    10
$a Chelating Polymers for Hereditary Hemochromatosis Treatment / $c O. Groborz, L. Poláková, K. Kolouchová, P. Švec, L. Loukotová, VM. Miriyala, P. Francová, J. Kučka, J. Krijt, P. Páral, M. Báječný, T. Heizer, R. Pohl, D. Dunlop, J. Czernek, L. Šefc, J. Beneš, P. Štěpánek, P. Hobza, M. Hrubý
520    9_
$a Hemochromatosis (iron overload) encompasses a group of diseases that are characterized by a toxic hyperaccumulation of iron in parenchymal organs. Currently, only few treatments for this disease have been approved; however, all these treatments possess severe side effects. In this study, a paradigm for hemochromatosis maintenance/preventive therapy is investigated: polymers with negligible systemic biological availability form stable complexes with iron ions in the gastrointestinal tract, which reduces the biological availability of iron. Macroporous polymer beads are synthesized with three different iron-chelating moieties (benzene-1,2-diol, benzene-1,2,3-triol, and 1,10-phenanthroline). The polymers rapidly chelate iron ions from aqueous solutions in vitro in the course of minutes, and are noncytotoxic and nonprooxidant. Moreover, the in vivo biodistribution and pharmacokinetics show a negligible uptake from the gastrointestinal tract (using 125 I-labeled polymer and single photon emission computed tomography/computed tomography), which generally prevents them from having systemic side effects. The therapeutic efficacy of the prepared polymers is successfully tested in vivo, and exhibits a significant inhibition of iron uptake from the gastrointestinal tract without any noticeable signs of toxicity. Furthermore, an in silico method is developed for the prediction of chelator selectivity. Therefore, this paradigm can be applied to the next-generation maintenance/preventive treatment for hemochromatosis and/or other diseases of similar pathophysiology.
650    _2
$a benzen $x chemie $x farmakologie $7 D001554
650    _2
$a gastrointestinální trakt $x účinky léků $7 D041981
650    _2
$a hemochromatóza $x diagnostické zobrazování $x farmakoterapie $x patologie $7 D006432
650    _2
$a lidé $7 D006801
650    _2
$a železo $x metabolismus $7 D007501
650    _2
$a chelátory železa $x chemie $x farmakologie $7 D007502
650    12
$a teoretické modely $7 D008962
650    _2
$a fenantroliny $x chemie $x farmakologie $7 D010618
650    _2
$a polymery $x chemie $x farmakologie $7 D011108
650    _2
$a tomografie emisní počítačová $7 D014055
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Poláková, Lenka $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic
700    1_
$a Kolouchová, Kristýna $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic $u Department of Physical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic
700    1_
$a Švec, Pavel $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic $u Department of Physical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic
700    1_
$a Loukotová, Lenka $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic
700    1_
$a Miriyala, Vijay Madhav $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo náměstí 542/2, 162 06, Prague 6, Czech Republic
700    1_
$a Francová, Pavla $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
700    1_
$a Kučka, Jan $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic
700    1_
$a Krijt, Jan $u Institute of Pathophysiology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 53, Prague 2, Czech Republic
700    1_
$a Páral, Petr $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
700    1_
$a Báječný, Martin $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
700    1_
$a Heizer, Tomáš $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
700    1_
$a Pohl, Radek $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo náměstí 542/2, 162 06, Prague 6, Czech Republic
700    1_
$a Dunlop, David $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo náměstí 542/2, 162 06, Prague 6, Czech Republic
700    1_
$a Czernek, Jiří $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic
700    1_
$a Šefc, Luděk $u Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
700    1_
$a Beneš, Jiří $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Salmovská 1, 120 00, Prague 2, Czech Republic
700    1_
$a Štěpánek, Petr $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic
700    1_
$a Hobza, Pavel $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo náměstí 542/2, 162 06, Prague 6, Czech Republic
700    1_
$a Hrubý, Martin $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského náměstí 2, 162 06, Prague 6, Czech Republic
773    0_
$w MED00006593 $t Macromolecular bioscience $x 1616-5195 $g Roč. 20, č. 12 (2020), s. e2000254
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32954629 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127144953 $b ABA008
999    __
$a ok $b bmc $g 1752087 $s 1155938
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 20 $c 12 $d e2000254 $e 20200921 $i 1616-5195 $m Macromolecular bioscience $n Macromol Biosci $x MED00006593
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace